ArticleEye (London, England)2024

Real world efficacy and durability of faricimab in patients with neovascular AMD (nAMD) who had sub-optimal response to prior anti-VEGF therapy.

Christine Goodchild et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.